Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Americo

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Virology|January 28, 2021
Loss of the vaccinia virus 35-amino acid hydrophobic O3 protein is partially compensated by mutations in the transmembrane domains of other entry proteinsAndrew I Tak, Jeffrey L Americo, Ulrike S Diesterbeck, et al.
NPJ Vaccines|March 27, 2023
Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to miceCatherine A Cotter, Jeffrey L Americo, Patricia L Earl, et al.
Journal of Virology|July 7, 2021
Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey CellsNoam Erez, Linda S Wyatt, Jeffrey L Americo, et al.
Mbio|June 8, 2017
Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral ProteinsLinda S Wyatt, Wei Xiao, Jeffrey L Americo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2022
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infectionJeffrey L Americo, Catherine A Cotter, Patricia L Earl, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 27, 2019
Growth and Purification of Vaccinia Virus Stocks for MPM ImagingGlennys V Reynoso, John P Shannon, Jeffrey L Americo, et al.
Journal of Virology|September 14, 2018
Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation InhibitionGilad Sivan, Shira G Glushakow-Smith, George C Katsafanas, et al.
Emerging Microbes & Infections|January 17, 2025
A functional approach to analyze the genetic basis for differences in virulence of monkeypox virus cladesPatricia L Earl, Jeffrey L Americo, Sara Reynolds, et al.
Mbio|February 22, 2022
Interferon α/β Decoy Receptor Encoded by a Variant in the Dryvax Smallpox Vaccine Contributes to Virulence and Correlates with Severe Vaccine Side EffectsRuikang Liu, Jeffrey L Americo, Patricia L Earl, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infectionRuikang Liu, Jeffrey L Americo, Catherine A Cotter, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Virology|January 28, 2021
Loss of the vaccinia virus 35-amino acid hydrophobic O3 protein is partially compensated by mutations in the transmembrane domains of other entry proteinsAndrew I Tak, Jeffrey L Americo, Ulrike S Diesterbeck, et al.
NPJ Vaccines|March 27, 2023
Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to miceCatherine A Cotter, Jeffrey L Americo, Patricia L Earl, et al.
Journal of Virology|July 7, 2021
Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey CellsNoam Erez, Linda S Wyatt, Jeffrey L Americo, et al.
Mbio|June 8, 2017
Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral ProteinsLinda S Wyatt, Wei Xiao, Jeffrey L Americo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2022
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infectionJeffrey L Americo, Catherine A Cotter, Patricia L Earl, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 27, 2019
Growth and Purification of Vaccinia Virus Stocks for MPM ImagingGlennys V Reynoso, John P Shannon, Jeffrey L Americo, et al.
Journal of Virology|September 14, 2018
Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation InhibitionGilad Sivan, Shira G Glushakow-Smith, George C Katsafanas, et al.
Emerging Microbes & Infections|January 17, 2025
A functional approach to analyze the genetic basis for differences in virulence of monkeypox virus cladesPatricia L Earl, Jeffrey L Americo, Sara Reynolds, et al.
Mbio|February 22, 2022
Interferon α/β Decoy Receptor Encoded by a Variant in the Dryvax Smallpox Vaccine Contributes to Virulence and Correlates with Severe Vaccine Side EffectsRuikang Liu, Jeffrey L Americo, Patricia L Earl, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infectionRuikang Liu, Jeffrey L Americo, Catherine A Cotter, et al.
Pageof 4